Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors - PubMed (original) (raw)

Case Reports

Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors

Kyoichi Takaori et al. J Hepatobiliary Pancreat Surg. 2003.

Abstract

Pancreatic intraepithelial neoplasia (PanIN) is a recently proposed nomenclature for putative precursor lesions of pancreatic cancer, which are designated as PanIN-1 through -3 according to their increasing grade of dysplasia. A stepwise progression model of PanINs has been proposed, and multistep genetic alterations in PanINs are being investigated. PanIN-1A and PanIN-1B may remain unchanged for a long period. PanIN-3 potentially progresses toward invasive ductal carcinoma (IDC), and there are several case reports suggesting such progression. In these reported patients, PanIN-3 was found in specimens from partial pancreatectomies, and IDC manifested in the pancreatic remnant 17 months to 29 years after the surgery. We describe herein a patient with PanIN-3, in whom IDC manifested in the distal remnant pancreas 69 months after segmental pancreatectomy. Of the reported cases, including the present one, four of the patients were male and three were female, and the age at the first operation ranged from 46 to 70 years. Intraductal papillary-mucinous tumor (IPMT) is an entity that is distinct from PanIN. However, IPMTs of small size resemble PanINs morphologically. Loss of Dpc4 expression has been reported in the invasive component of IPMT, as well as in PanIN-3 and IDC. Analysis of mucin expression patterns has been reported, suggesting that, in practice, MUC1-positive MUC2-negative IPMTs may not be distinguishable from PanINs. There may be overlapping lesions between PanINs and IPMTs. Should the paradigm of the ductal origin of IDC be accepted, PanINs and a fraction of IPMTs would represent precursors of IDC.

PubMed Disclaimer

Cited by

A case of pancreatic intraepithelial neoplasia that was difficult to diagnose preoperatively.
Ito H, Kawaguchi Y, Kawashima Y, Maruno A, Ogawa M, Hirabayashi K, Mine T. Ito H, et al. Case Rep Oncol. 2015 Jan 22;8(1):30-6. doi: 10.1159/000371842. eCollection 2015 Jan-Apr. Case Rep Oncol. 2015. PMID: 25762925 Free PMC article.
Microinvasion of high-grade pancreatic intraepithelial neoplasia.
Kawada N, Uehara H, Takada R, Yamai T, Fukutake N, Katayama K, Takenaka A, Nagata S, Tomita Y. Kawada N, et al. Case Rep Gastroenterol. 2013 Jan;7(1):30-6. doi: 10.1159/000346693. Epub 2013 Jan 23. Case Rep Gastroenterol. 2013. PMID: 23466672 Free PMC article.
Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.
Nakajima Y, Yamada T, Sho M. Nakajima Y, et al. Surg Today. 2010 Sep;40(9):816-24. doi: 10.1007/s00595-009-4227-y. Epub 2010 Aug 26. Surg Today. 2010. PMID: 20740343 Review.
Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biology.
Verbeke CS. Verbeke CS. World J Gastrointest Surg. 2010 Oct 27;2(10):306-13. doi: 10.4240/wjgs.v2.i10.306. World J Gastrointest Surg. 2010. PMID: 21160835 Free PMC article.
Intraductal papillary mucinous neoplasm originating from a jejunal heterotopic pancreas: report of a case.
Okamoto H, Fujishima F, Ishida K, Tsuchida K, Shimizu T, Goto H, Sato A, Satomi S, Sasano H. Okamoto H, et al. Surg Today. 2014 Feb;44(2):349-53. doi: 10.1007/s00595-012-0486-0. Epub 2013 Jan 18. Surg Today. 2014. PMID: 23325495 Review.

Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors - PubMed (original) (raw)